Jan Alfheim is the founder of Oncoinvent. Oncoinvent has raised $26M in total funding. Backed by Hadean Ventures, Geveran, RADFORSK Investeringsstiftelse.
Jan Alfheim is the former Chief Executive Officer of Oncoinvent AS, a Norwegian clinical-stage radiopharmaceutical company. He served as CEO during key financing rounds, including a 40 million NOK round in 2020 and a planned 150–200 million NOK private placement in 2021. He resigned as CEO, and new board members were subsequently elected.
Full founder directory · Investor directory · Company funding database · Fundraising library